BackAcasti Pharma Overview

Acasti Pharma Accounts Payable

Track Acasti Pharma's accounts payable ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer average / median

Loading

Acasti Pharma Accounts Payable History

Loading

Acasti Pharma vs. peers: Accounts Payable Comparison

Loading

Acasti Pharma Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Acasti Pharma (ACST) FAQ

The latest accounts payable for ACST is $0 as of March 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Acasti Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, ACST's accounts payable moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Acasti Pharma's operating scale or balance-sheet position.

A accounts payable figure of $0 for ACST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ACST's accounts payable ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Acasti Pharma's accounts payable against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.